Web-based Physical Activity Intervention Among Children and Adolescents with Cancer
A Randomized, Phase III, Web-based Physical Activity Intervention in Improving Long-Term Health in Children and Adolescents With Cancer
About
Protocol Description
Childhood cancer survivors are at elevated risk for obesity, low bone mineral density, cardiomyopathy, peripheral neuropath and altered psychosocial functioning. Children with cancer are likely to adopt a sedentary lifestyle that persists long into survivorship, and a sedentary lifestyle may perpetuate or exacerbate many of the complications experienced by survivors. Research is needed to provide survivors with tools to improve their long-term health.
COG# ALTE1631
Eligibility Criteria
Inclusion Criteria
- Diagnosis: All cancer cases with an ICD-O histologic behavior code of two (2) or three (3) in remission.
- Age: Patient must be ≥ 8 years of age and < 16 years of age at time of enrollment.
- Prior therapy: Patient must have completed curative therapy (surgery and/or radiation and/or chemotherapy) within the past 12 months at a Children's Oncology Group institution.
- Patient and at least one parent/guardian can read and write in English, Spanish and/or French.
Exclusion Criteria
- Patients with previous hematopoietic stem cell transplant (HSCT).
- Patients with a cognitive, motor, visual or auditory impairment that prevents computer use are not eligible.
- Female patients who are pregnant.
See Protocol Section 3 for a complete comprehensive list of inclusion and exclusion criteria.
Primary Investigator
Dr. Glenn Edwards is the section chief of Pediatric Hematology/Oncology, as well as the Children's Oncology Group's principal investigator for Carilion Clinic. He has over 30 years of clinical experience and is board certified by the American Board of Pediatrics in Pediatrics and Pediatric Hematology/Oncology. He completed his fellowship at Walter Reed Army Medical Center and completed his internship and residency at Tripler Army Medical Center.
Contact Information
Wendy McCarty, C.C.R.P.
Clinical Research Coordinator II
